Company Filing History:
Years Active: 2023-2025
Title: Umrao Monani: Innovator in Biologic Treatments
Introduction
Umrao Monani is a notable inventor based in Oradell, NJ (US). He has made significant contributions to the field of biologic treatments, holding 2 patents that focus on innovative methods for addressing various health conditions.
Latest Patents
Monani's latest patents include "SLC2A1 lncRNA as a biologic and related treatments." This invention relates to a novel antisense transcript to the human SLC2A1 (Glut1) gene, including its variants and fragments. The antisense transcript can be utilized to modulate Glut1 expression, serving as a therapeutic approach for treating or preventing Glut1 deficiency syndrome and other related conditions such as certain cancers, diabetes, Alzheimer's disease, and retinitis pigmentosa. Another significant patent is "Compositions and methods for treating motor neuron diseases," which provides compositions and methods for treating conditions like spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). This method may involve a modulator of a heat shock protein, such as an Hsp70 family member protein, or a mutant heat shock protein.
Career Highlights
Throughout his career, Monani has worked with prestigious institutions, including Columbia University and the University of Massachusetts. His work has significantly impacted the understanding and treatment of various diseases.
Collaborations
Some of his notable coworkers include Jeong Ki-Kim and Maoxue Tang.
Conclusion
Umrao Monani's innovative work in biologic treatments showcases his dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues through novel approaches.